Researchers have developed a structured strategic pathway for medical device innovation by integrating Interpretive Structural Modeling and the Decision-Making Trial and Evaluation Laboratory method to organize eighteen critical development factors across seven hierarchical levels. According to the investigation published in BMC Health Services Research, Clinical Needs Assessment operates as the fundamental root-driving factor that initiates the entire progression. By combining these analytical methods, the authors established a directional framework that models the interdependencies among competing priorities encountered during technology commercialization. The resulting model maps the complex innovation landscape into a coherent seven-phase pathway designed to guide decision-makers through the sequential phases required to translate medical concepts into clinical practice.
The strategic pathway addresses systemic operational hurdles that confront emerging ventures across the biomedical startup industry. Developing biomedical innovations necessitates continuous adaptation to evolving clinical demands alongside ongoing structural changes across modern healthcare systems. Startup enterprises routinely encounter multifaceted barriers at every stage of development, extending from early scientific investigation to formal market entry. The research team noted that existing academic and management literature has lacked a systematic framework for sequencing strategic priorities within the Medical Device Innovation Process. Without structured guidance, early-stage enterprises frequently struggle to determine which technical and operational factors should receive immediate focus when resources are severely constrained.
To identify the core elements of the innovation process, the study gathered primary empirical data from specialized professionals at the BioMed Commercialization Center. The investigators conducted structured interviews with thirty-nine experts representing the center, including members of review committees, active project managers, and innovation team participants. Following these qualitative interviews, the researchers administered an empirical survey to sixty experienced biomedical practitioners to evaluate the identified factors. A total of fifty-two questionnaires were returned by the respondents, yielding thirty-five completed submissions that met the necessary criteria for rigorous quantitative analysis. Through content analysis of the interview findings, the researchers systematically isolated eighteen distinct factors that govern the medical device innovation process.
The researchers subsequently utilized a two-step modeling methodology to establish hierarchical relationships and quantify directional influences among the identified elements. Interpretive Structural Modeling was first applied to organize the eighteen factors into seven clear hierarchical tiers, revealing their foundational dependencies. The Decision-Making Trial and Evaluation Laboratory method was then deployed to analyze the net influences exerted among factors located within each hierarchical level. This approach expanded upon the team’s earlier research, which had relied solely on Interpretive Structural Modeling, by clarifying the directional interactions between concurrent factors. The resulting seven-phase pathway systematically connects clinical needs, clinical and regulatory planning, market feasibility, business model development, technology implementation, production assessment, supply chain planning, and intellectual property protection.
The integrated framework offers an analytical foundation designed to assist practitioners in navigating the complex web of interactions that characterizes device development under constrained operational resources. By clarifying the relative ordering and causal dependencies among essential development criteria, the pathway outlines how foundational steps support downstream execution in commercialization efforts. However, the study authors emphasized that the structured pathway currently reflects an analytical modeling construct derived from expert assessments rather than measured commercial outcomes. Further empirical validation remains necessary to evaluate whether implementing the proposed framework directly improves innovation performance or optimizes resource allocation across active biomedical startup ventures.
Subject of Research: Strategic decision-making frameworks for medical device innovation in biomedical startups
Article Title: An ISM-DEMATEL approach for developing a structured strategic pathway in medical device innovation
Article References: Tseng, M.-H., Lian, J.-Y., Liu, A.-S., & Chen, P.-T. (2026). An ISM-DEMATEL approach for developing a structured strategic pathway in medical device innovation. BMC Health Services Research. https://doi.org/10.1186/s12913-026-15863-7
Image Credits: AI Generated
DOI: 10.1186/s12913-026-15863-7
Keywords: medical device innovation, biomedical startups, strategic pathway, interpretive structural modeling, DEMATEL, healthcare technology, clinical needs assessment, decision-making prioritization, ISM-DEMATEL, approach, developing, structured
News Source: Ophelia Keating. (November 10, 2026). New Strategic Modeling Pathway Maps Priority Stages for Medical Device Startups. Scienmag.



